IT&E International Group, Inc. (OTCBB: ITER), a life sciences service organization and full-service clinical research organization (“CRO”), today announced that it has completed a series of transactions under the Agreement and Plan of Merger announced on July 6, 2006, with privately held Averion Inc., a Massachusetts corporation. The transactions have resulted in a clinical research organization with unique therapeutic areas of expertise. The newly combined companies will move headquarters to the Averion office located in the Boston, Massachusetts suburb of Southborough. In addition, IT&E International Group, Inc. intends to change its name to Averion International Corp. and expects that its OTCBB trading symbol will also be changed to reflect the name change.
